Moreover, PD-L1 expression on DCs is known to be pivotal in modulating T-cell responses via PD-1 interaction within tumor-draining LNs.48 This interaction is likely to be weakened by anti-lymphangiogenesis therapy, mainly due to the decreased number of DCs in the tumor-draining LNs. The gene discussed is CD274; the disease is neoplasm.